Tg01 Vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tg01 Vaccine, covering 2024-09-23 to 2025-08-05. Get the full timeline:
Most recent: Clinical Trial Update: The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma [Phase 1, Phase 2]